Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: This release doesn't discusscosts in its comparison of influenza shots versus nasal sprays, although both modes of immunization have been around for a long while and the costs for both are easily known. Whileflu immunizations are often free through public health clinics and such, somepeople receive their immunizations from their family physicians and carry a specific cost. Knowing the difference in costs between the two typesis useful information both for people and public health officials. The release reports similar rates of vaccine uptake for intranasal vaccine and standard flu shots. But it does not quantify benefits for the main outcome of the study, that is, rates of influenza in communities vaccinated with nasal vs injected vaccine over the course of the study. These rates were statistically no different: 5.2% for the standard vs 5.3% for the nasal vaccine. This release makes no mention of possible harms that my follow the use of either the influenza vaccine injections or nasal spray, even though there are well-known restrictions on whom should and should not receive the nasal spray, and potential negative reactions to the injections among some people. The release points out that the study was the "first blinded randomized controlled trial" done in children within largely closed communities and it found similar efficacy in using the two modes of immunization. However, we do wish the release had addressed limitations, as well as some of the complexity of making these results generalizable to a larger population, as we saw with NPR's take on the news. While media attention is routinely heightened leading up to and during flu season, this release does not appear to reach the level of disease mongering. The release does identify the chief funder of the study, the Canadian Institutes for Health Research, although it offers no information on possible conflicts of interest among any of the researchers. The abstractof the study does state that two of the researchers do have links to pharmaceutical firms, but not in relation this study. Since the study looked a two forms of influenza vaccine administration, it obviously addresses the question of comparing alternatives. Both forms of immunization shots and nasal spray have been around for some time, their availability is widely known, earning the release a Satisfactory in this category. The release makes clear that the novelty of this study is its ability to examine both indirect effects of vaccination on the community as well as direct effects for persons receiving the vaccine. The release does not use any unjustifiable language.
[EX A]: Flu nasal spray provides similar protection against influenza as flu shot: Study

[EX Q]: Use of such pills, which include Sanofi SA's Ambien and other similar drugs, was significantly higher for those in their 50s as well as age 80 and older, according to the findings from the Centers for Disease Control and Prevention. Overall about 8.6 million people, or 4 percent of U.S. adults reported recently using sleep medication, CDC's National Center for Health Statistics said in a report. But data showed higher use among middle-aged adults ages 50 to 59 and the elderly. Six percent of those ages 50 to 59 said they had taken a prescription sleep pill in the last 30 days, and 7 percent of those age 80 and older reported such use. In between, the numbers dip slightly below 6 percent for those in their 60s and 70s. In comparison, just 2 percent of those aged 20-39 said they had recently taken a sleep aid. CDC researcher Yinong Chong said people in their 50s could have trouble sleeping because of work and family stress. "It gives the picture of a sandwiched group who has family, not only children but also probably elderly parents but still you're likely to be in the workforce, so you get squeezed at both ends in terms of family responsibility and job responsibility," she said. Sleep may improve when people retire before potential chronic health problems kick in and begin interfering with sleep, Chong said, adding more study is needed. The data also showed that 5 percent of women surveyed said they had recently taken a sleep aid compared to about 3 percent of male respondents, according to CDC's report. Chong said it was not clear why women were more likely to use the drugs. While previous data have tracked prescriptions dispensed for sleep aids, the CDC said its study is the first based on a survey of actual use of such drugs. Researchers for the Atlanta-based health agency's National Center for Health Statistics questioned a sampling of adults age 20 and older about whether they had used prescription sleep aids within the last 30 days and asked participants to show interviewers the prescription medication. "You get how many people are actually using them," Chong said in an interview, noting that prescription data could include multiple prescriptions for one patient or prescriptions that are never filled or even used. "This is actual use." Prescription sleep aids have become somewhat controversial because their effect can linger even after some patients wake up. The U.S. Food and Drug Administration has begun taking a closer look at sleep drugs, ordering lower-doses for Ambien and similar pills amid concerns that their active ingredient remained in patients' blood the following morning at levels high enough to make driving and other activities dangerous. And just last month, the FDA rejected an experimental sleep drug from Merck & Co Inc, saying the proposed doses were not safe but that a lower-dose version might be acceptable. Not surprisingly, respondents to CDC's study who said they slept five hours or less each night or those diagnosed with a sleep disorder were more likely to report using prescription aids. Additionally, more whites and people with higher levels of education also reported greater use, the agency said. Socioeconomic factors are likely behind those numbers, Chong said, since patients must be able to afford a doctor's care and the medication. According to prescription data from IMS Health, Ambien and other versions of the drug zolpidem was ranked 15th among the most dispensed medications in the United States.
[EX A]: Use of sleeping pills highest among older Americans: CDC.

[EX Q]: The Utah Senate and House of Representatives voted unanimously Monday evening during a special session to send the proposal to Republican Gov. Gary Herbert's desk. The measure would replace plans for an unusual state-run dispensary system with 14 privately run pharmacies and adopt protections for patients who are concerned they could be prosecuted for drug crimes, among other changes. Utah backtracked from the state-run dispensary after county attorneys expressed concern that such a system would put public employees at risk of being prosecuted under federal drug laws. Republican Senate Majority Leader Evan Vickers, who drafted the law, said his team is "doing everything we can" to improve patient access and have product ready by next March. Some lawmakers said they still have heartburn over certain aspects of the bill, sharing reservations about product distribution and a looming fear of federal prosecution. Democratic Sen. Derek Kitchen said he's concerned patients in rural parts of the state may have to pay more to access marijuana. Before the House vote, Republican Rep. Keven Stratton suggested Utah seek a federal waiver to protect the state program from prosecution under federal drug laws. Marijuana is banned at the federal level, though a congressional amendment blocks the Justice Department from interfering with states' medical marijuana programs. The measure dictated that the courts may not treat a medical marijuana patient differently than someone who uses any other prescribed, controlled substance. Another change prohibited the state from issuing cultivation and pharmacy licenses to legislators. "A lot of money flows through this industry, some back to legislators," Vickers said. "We don't want legislators to have undue influence in an industry they want to have ownership in." Debates in the chamber reflected ongoing tensions over amendments regarding distribution and prosecution of drug crimes. During a tense public hearing last week, members of the conservative group Utah Eagle Forum lamented the loss of the state-run dispensary system, while some medical marijuana advocates raised concern that there wouldn't be enough private dispensaries to meet growing patient demand. An earlier version of the law imagined 12 privately run dispensaries instead of the state-run system. In the same meeting, a proposal outlining patient protections caused an emotional back-and-forth between conservative attorneys who argued parents couldn't take care of children while using marijuana and patients who said the drug makes them better caretakers and helps them manage their pain. Utah residents voted to legalize medical marijuana via ballot measure in November. The revised law became effective in December after a compromise that secured the support of The Church of Jesus Christ of Latter-day Saints and some marijuana advocates. However, the deal drew backlash from other advocates as it banned many marijuana edibles, placed additional restrictions on growing cannabis and made fewer medical conditions eligible for treatment with pot. Other changes addressed issues with land ordinances for cultivation facilities and marijuana research at in-state universities. Marijuana advocates said they are optimistic about the changes adopted. "There's a light at the end of the tunnel, we see legislators working together, and they're willing to work out a plan for patients," Desiree Hennessy, director of the Utah Patients Coalition, said. Republican Rep. Brad Daw acknowledged the measure as a good first step but expects additional changes to the program in January. "I have close friends who, for them, cannabis is the only option, it relieves the kind of pain they have ... we have every right and responsibility to work toward a law that allows medical cannabis to patients who need it," he said. "Is this bill perfect? Of course not. Is this done? No, it's not."
[EX A]:
Utah lawmakers approve changes to medical cannabis law.